BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35429230)

  • 21. Prevention of ribosome collision-induced neuromuscular degeneration by SARS CoV-2-encoded Nsp1.
    Wang X; Rimal S; Tantray I; Geng J; Bhurtel S; Khaket TP; Li W; Han Z; Lu B
    Proc Natl Acad Sci U S A; 2022 Oct; 119(42):e2202322119. PubMed ID: 36170200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parsing the role of NSP1 in SARS-CoV-2 infection.
    Fisher T; Gluck A; Narayanan K; Kuroda M; Nachshon A; Hsu JC; Halfmann PJ; Yahalom-Ronen Y; Tamir H; Finkel Y; Schwartz M; Weiss S; Tseng CK; Israely T; Paran N; Kawaoka Y; Makino S; Stern-Ginossar N
    Cell Rep; 2022 Jun; 39(11):110954. PubMed ID: 35671758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein.
    Rao S; Hoskins I; Tonn T; Garcia PD; Ozadam H; Sarinay Cenik E; Cenik C
    RNA; 2021 Sep; 27(9):1025-1045. PubMed ID: 34127534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
    Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
    J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
    Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Basis of SARS-CoV-2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches.
    Francés-Monerris A; Hognon C; Miclot T; García-Iriepa C; Iriepa I; Terenzi A; Grandemange S; Barone G; Marazzi M; Monari A
    J Proteome Res; 2020 Nov; 19(11):4291-4315. PubMed ID: 33119313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling studies reveal the importance of the C-terminal inter motif loop of NSP1 as a promising target site for drug discovery and screening of potential phytochemicals to combat SARS-CoV-2.
    Prabhu D; Rajamanikandan S; Sureshan M; Jeyakanthan J; Saraboji K
    J Mol Graph Model; 2021 Jul; 106():107920. PubMed ID: 33933885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. I(nsp1)ecting SARS-CoV-2-ribosome interactions.
    Simeoni M; Cavinato T; Rodriguez D; Gatfield D
    Commun Biol; 2021 Jun; 4(1):715. PubMed ID: 34112887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and HDX Mass Spectral Characterization of the SARS-CoV-2 Nsp1 Protein.
    Mishra N; Kant R; Leung DW; Gross ML; Amarasinghe GK
    Biochemistry; 2023 Jun; 62(11):1744-1754. PubMed ID: 37205707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of 5'UTR to evade SARS-CoV-2 Nonstructural protein 1-directed inhibition of protein synthesis in cells.
    Chen SC; Xu CT; Chang CF; Chao TY; Lin CC; Fu PW; Yu CH
    Appl Microbiol Biotechnol; 2023 Apr; 107(7-8):2451-2468. PubMed ID: 36843199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
    Banerjee AK; Blanco MR; Bruce EA; Honson DD; Chen LM; Chow A; Bhat P; Ollikainen N; Quinodoz SA; Loney C; Thai J; Miller ZD; Lin AE; Schmidt MM; Stewart DG; Goldfarb D; De Lorenzo G; Rihn SJ; Voorhees RM; Botten JW; Majumdar D; Guttman M
    Cell; 2020 Nov; 183(5):1325-1339.e21. PubMed ID: 33080218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of 82-85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication.
    Gori Savellini G; Anichini G; Manetti F; Trivisani CI; Cusi MG
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended ensemble simulations of a SARS-CoV-2 nsp1-5'-UTR complex.
    Sakuraba S; Xie Q; Kasahara K; Iwakiri J; Kono H
    PLoS Comput Biol; 2022 Jan; 18(1):e1009804. PubMed ID: 35045069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural investigations of proteins encoded by SARS-CoV-2.
    Wlodawer A
    FEBS Open Bio; 2022 Sep; 12(9):1562-1563. PubMed ID: 36045569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression.
    Nakagawa K; Makino S
    Cells; 2021 Feb; 10(2):. PubMed ID: 33540583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 targets ribosomal RNA biogenesis.
    Yerlici VT; Astori A; Kejiou NS; Jordan CA; Khosraviani N; Chan JNY; Hakem R; Raught B; Palazzo AF; Mekhail K
    Cell Rep; 2024 Mar; 43(3):113891. PubMed ID: 38427561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Basis of SARS-CoV-2 Nsp1-Induced Immune Translational Shutdown as Revealed by All-Atom Simulations.
    Borišek J; Spinello A; Magistrato A
    J Phys Chem Lett; 2021 Dec; 12(48):11745-11750. PubMed ID: 34851631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening.
    Ma S; Damfo S; Lou J; Pinotsis N; Bowler MW; Haider S; Kozielski F
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation.
    Kumar P; Schexnaydre E; Rafie K; Kurata T; Terenin I; Hauryliuk V; Carlson LA
    FEBS Lett; 2022 May; 596(9):1203-1213. PubMed ID: 35434785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural, Biophysical, and Biochemical Elucidation of the SARS-CoV-2 Nonstructural Protein 3 Macro Domain.
    Lin MH; Chang SC; Chiu YC; Jiang BC; Wu TH; Hsu CH
    ACS Infect Dis; 2020 Nov; 6(11):2970-2978. PubMed ID: 32946224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.